Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-003460

Options or other derivatives

  • COO acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LEE WILLIS C COO 2023-01-12 Grant or award · Options +750,000 $4.50 $3,375,000 750,000 D
Loading xslF345X03/doc4.xml…